Before visiting, please review our current visitor policies and COVID-19 information.
Biodesix, Inc. BDX-00146
An observational study assessing the clinical effectiveness of the VeriStrat test and validation immunotherapy tests in subjects with non-small cell lung cancer
To collect information about how the study doctor uses the results of the VeriStrat blood test to choose treatment for NSCLC.
DiagnosisNon-small cell lung cancer.
No prior treatment necessary.
Patients must sign an approved informed consent and authorization permitting release of personal health information.
- There are no required treatments for this study, only blood draws and results.
- If EGFR gene status is unknown, additional blood will be drawn for testing.
Involvement in this study will last for 18 months.
For more information, visit ClinicalTrials.gov
Key Participation Requirements
Male or Female
19 years and older
Methodist Health System Trial Code